healthcarenewswire

The high growth is expected due to the increasing government initiatives for the adoption of EHR systems, rising adoption of healthcare intranet technologies (HCIT), rising usage of EHR solutions, and need to reduce the overall healthcare cost.

Due to the development of cloud-based ambulatory EHR solutions, it is possible to keep data safe, secure and fully accessible regardless of time or network traffic. Cloud based solutions require less capital investment, demand fewer IT resources, take up less space, and update automatically, resulting in significant cost savings for clinics without requiring extra time and staff to support bulky hardware installations. The implementation of EHR systems is simpler as it runs on the web instead of computer that means there is no requirement of any software or hardware. Also, cloud-based solutions do not require any hardware installation or software licenses, therefore the implementation cost is very less. Cloud-based EHR solutions require HIPAA compliance through data centers with bank-level security and high-level encryption methods that render data unreadable. Due to several advantages offered by cloud based ambulatory EHR, demand of cloud based ambulatory EHR is increasing. The increasing demand of cloud-based solution is likely to create opportunities for the players in the ambulatory EHR market to develop more advanced solutions.

The U.S. scar treatment market size is expected to reach $11.3 billion by 2023. The market is mainly driven by increasing number of surgeries for the improvement of physical appearance, growing prevalence of skin problems leading to scar formation, increasing expenditure on personal care, and technological advancements in dermatological products.

Get report sample at@ http://bit.ly/2N5Qc9n

The agricultural biotechnology market size is projected to cross $55.5 million by 2023, growing at a CAGR of 10.1% during 2017-2023. The market is growing mainly due to the increasing demand of agricultural biotechnology products include; the growing population size, rising per capita income, growing demand for biofuel, thriving demand for transgenic crops and regulatory support in the U.S. and Brazil.

The global agricultural biotechnology market in terms of product is bifurcated into transgenic seeds and crop protection products. Transgenic seeds accounted for the larger market share of 79.5% during the forecast period, attributed to their increasing adoption of these to prevent the impact of adverse climatic conditions such as droughts in the region. Also, rising global population is putting pressure on farmlands to produce more food, especially in developing countries such as India, China and given that the area under cultivation cannot be increased beyond a certain limit, the only way to increase production is through yield improvements, thus increasing the demand for transgenic seeds.

The anti-aging market growing at a CAGR of 8.0% between 2017-2025. Technological advancements, increase in volume of anti-aging procedures, growing aging population and increase in disposable income have been driving the anti-aging industry. The market is further expected to gain revenue due to increase in anti-aging awareness campaigns. For instance, EuroMediCom organized the 15th Aesthetic & Anti-Aging Medicine World Congress from 6th April to 8th April, 2017, in Monaco.

Download free report sample at: http://bit.ly/2gvOpYy

Global cell isolation market size is expected to reach $12.6 billion by 2023. The market is mainly driven by rising demand for biopharmaceuticals, increasing government funding for cell-based research, and growing research on personalized medicine.

The cell isolation market is also categorized into human cells and animal cells. During the forecast period, the market is expected to witness higher growth in human cell isolation, with a CAGR of 19.9%. Advancements in stem cell technologies for the treatment of various diseases are expected to drive the cell isolation market growth for this category.

The mass spectrometry market size is projected to reach $8.5 billion by 2022, growing at a CAGR 2016-2022. 

The demand for mass spectrometry is growing rapidly in life science and clinical sector. Some of its most common applications in life science and clinical studies are determination of protein structure, interactions and folding; protein identification from the mass of its peptide fragment; relative or absolute quantification of proteins in a given sample; monitoring of enzyme reactions; chemical modifications; protein digestion; forensic analysis; and disease biomarkers detection. All these applications are very vital in life science and clinical studies and with increasing healthcare awareness, advanced research and development, increasing cases of drug abuse, and high number of metabolic diseases, the demand for mass spectrometer is rapidly growing. Mass spectrometer is an important analytical tool for the study of proteins. Proteomics is very difficult to analyse and study, due to the complexity of its structures. Mass spectrometry helps to analyse the composition of different biological samples and offers quantitative proteogenomics and proteomics. All these factors tend to drive the growth of the mass spectrometry market.

The global medication management market is growing at a significant rate, due to growing demand for advanced healthcare information system, and growing investments by HIT players. In addition, the growing need for remote patient monitoring services, increasing demand of mHealth technologies, and increasing support from government organizations are also driving the growth of the global medication management market.

Request for report sample at@ http://bit.ly/2zh1OLb

The molecular biology kits and reagents and enzymes market is expected to reach $15.0 billion by 2022, growing at a CAGR of 17.2% between 2016-2022. The molecular biology kits and reagents and enzymes market is growing due to increasing geriatric population, increasing prevalence of infectious diseases, and growing cases with genetic disorders. In addition, increasing healthcare expenditure resulting in improvement in research activities is further driving the market growth.

Request for report sample at: http://bit.ly/2z6RxnP

According to a new research report published by P&S Intelligence, the global population health management (PHM) market size is predicted to cross $48.1 billion by 2022. The global population health management market is growing at a significant rate, due to growing geriatric population, regulatory mandate under the Affordable Care Act (ACA) and increasing prevalence of chronic and lifestyle associated diseases.

Get sample copy at@ http://bit.ly/2KgOtLJ

The growth in the healthcare cognitive computing industry size will be led by increasing burden of chronic diseases, technological advancements in the healthcare industry encouraging the use of cognitive computing in healthcare, and rising adoption of third computing platforms.

Download free report sample at: http://bit.ly/2I8VolC